Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edesa Biotech (EDSA) Receivables - Net (2016 - 2022)

Edesa Biotech's Receivables - Net history spans 10 years, with the latest figure at $1.4 million for Q2 2022.

  • For Q2 2022, Receivables - Net fell 66.46% year-over-year to $1.4 million; the TTM value through Jun 2022 reached $1.4 million, down 66.46%, while the annual FY2021 figure was $3.3 million, 3676.99% up from the prior year.
  • Receivables - Net for Q2 2022 was $1.4 million at Edesa Biotech, up from $1.2 million in the prior quarter.
  • Across five years, Receivables - Net topped out at $7.8 million in Q1 2021 and bottomed at $7339.0 in Q4 2018.
  • The 5-year median for Receivables - Net is $109600.0 (2019), against an average of $1.3 million.
  • The largest annual shift saw Receivables - Net soared 9187.72% in 2021 before it crashed 84.0% in 2022.
  • A 5-year view of Receivables - Net shows it stood at $7339.0 in 2018, then soared by 1393.39% to $109600.0 in 2019, then surged by 53.31% to $168030.0 in 2020, then soared by 1611.76% to $2.9 million in 2021, then tumbled by 51.2% to $1.4 million in 2022.
  • Per Business Quant, the three most recent readings for EDSA's Receivables - Net are $1.4 million (Q2 2022), $1.2 million (Q1 2022), and $2.9 million (Q4 2021).